DBD Stock: Price, Earnings History and SEC Filings
Diebold Nixdorf, Incorporated (DBD) last traded at $55.05, down 6.92% on the latest session and down 10.1% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $1.34 against an analyst estimate of $1.31, a beat of 2.3%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
DBD earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 28, 2026 | $1.34 | $1.31 | +2.29% |
| Jun 2026 | Jul 29, 2026 | $1.10 | $1.10 | +0.00% |
| Mar 2026 | Apr 30, 2026 | $0.60 | $0.61 | -1.64% |
| Dec 2025 | Feb 12, 2026 | $2.75 | $1.73 | +58.96% |
DBD beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
How DBD reacts to earnings
Across its last 8 earnings releases, DBD moved 8.5% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-10-28 | Before open | -12.91% |
| 2026-07-29 | Before open | -17.17% |
| 2026-04-30 | Before open | -7.41% |
| 2026-02-12 | Before open | +4.46% |
| 2025-11-05 | Before open | +12.45% |
| 2025-08-06 | Before open | +5.78% |
| 2025-05-07 | Before open | -2.76% |
| 2025-02-12 | Before open | +5.36% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
DBD financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $3.8B | $95M | – | 2.5% | $2.54 |
| 2024 | $3.8B | -$17M | – | -0.4% | $-0.44 |
| 2022 | $3.5B | -$581M | – | -16.8% | $-7.36 |
| 2021 | $3.9B | -$79M | – | -2.0% | $-1.01 |
| 2020 | $3.9B | -$269M | – | -6.9% | $-3.47 |
| 2019 | $4.4B | -$341M | – | -7.7% | – |
| 2018 | $4.6B | -$531M | – | -11.6% | $-7.48 |
| 2017 | $4.6B | -$242M | – | -5.2% | $-3.20 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for DBD
- 10-Q · Oct 28, 2026
- 8-K · Oct 28, 2026Results of operations, Financial statements and exhibits
- 10-Q · Jul 29, 2026
- 8-K · Jul 29, 2026Results of operations
- 8-K · May 26, 2026Shareholder vote
- 10-Q · Apr 30, 2026
- 8-K · Apr 30, 2026Results of operations
- DEF 14A · Apr 2, 2026
- 8-K · Feb 25, 2026Officer or director change
- 10-K · Feb 12, 2026
Insider filing activity
DBD insiders filed 0 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
DBD news
- 5 insightful analyst questions from Diebold Nixdorf’s Q3 earnings callOct 31, 2026 · finance.yahoo.com
- Why Diebold Nixdorf Stock Is Down 6.9% And What's NextOct 30, 2026 · finance.yahoo.com
- Why Diebold Nixdorf (DBD) shares are falling todayOct 29, 2026 · finance.yahoo.com
- Diebold Nixdorf Q3 Earnings Call HighlightsOct 28, 2026 · marketbeat.com
- Diebold Nixdorf (DBD) Q3 2026 Earnings Call TranscriptOct 28, 2026 · fool.com
- Diebold Nixdorf, Incorporated Q3 2026 Earnings Call SummaryOct 28, 2026 · app.moby.co
- Diebold Nixdorf Sinks 10% on Guidance Cut Driven by “Elevated Component Costs”: The Memory Trade ContinuesOct 28, 2026 · tikr.com
- Diebold Nixdorf lowers full-year outlook, announces share buybackOct 28, 2026 · cantonrep.com
About Diebold Nixdorf, Incorporated
Diebold Nixdorf, Incorporated (DBD) is a US-listed public company on NYSE. The SEC classifies its business as Calculating & Accounting Machines (no Electronic Computers). It is incorporated in DE. Its fiscal year ends in December.